Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Diabetic kidney disease: an update
S Gupta, M Dominguez, L Golestaneh - Medical Clinics, 2023 - medical.theclinics.com
Diabetes is a major public health challenge in both developed and develo** countries. It
is estimated that in 2030, 643 million people will be living with diabetes. 1 About 1 in 10 …
is estimated that in 2030, 643 million people will be living with diabetes. 1 About 1 in 10 …
The Na/K-ATPase signaling and SGLT2 inhibitor-mediated cardiorenal protection: a crossed road?
In different large-scale clinic outcome trials, sodium (Na+)/glucose co-transporter 2 (SGLT2)
inhibitors showed profound cardiac-and renal-protective effects, making them revolutionary …
inhibitors showed profound cardiac-and renal-protective effects, making them revolutionary …
Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells
L Li, H Liu, Q Chai, J Wei, Y Qin, J Yang, H Liu… - Cellular and Molecular …, 2024 - Springer
Vascular calcification is a complication that is frequently encountered in patients affected by
atherosclerosis, diabetes, and chronic kidney disease (CKD), and that is characterized by …
atherosclerosis, diabetes, and chronic kidney disease (CKD), and that is characterized by …
[PDF][PDF] Dapagliflozin for Chronic Kidney Disease
SD Khangura, M Severn - Canadian Journal of Health …, 2022 - canjhealthtechnol.ca
AE adverse event AF atrial fibrillation CKD chronic kidney disease CI confidence interval CV
cardiovascular eGFR estimated glomerular filtration rate DAPA-CKD Dapagliflozin and …
cardiovascular eGFR estimated glomerular filtration rate DAPA-CKD Dapagliflozin and …
Renoprotective Mechanisms of SGLT2 Inhibitors in Type 2 Diabetes Patients with Chronic Kidney Disease
LHCC Pinto - Renoprotective Mechanisms of SGLT2 Inhibitors in …, 2022 - estudogeral.uc.pt
Background: Diabetes mellitus is a global epidemic estimated to affect more than 420 million
people worldwide and predicted to impact about 630 million until 2045. Chronic kidney …
people worldwide and predicted to impact about 630 million until 2045. Chronic kidney …
Drug Effect of Loxofen Sodium Tablets on Pain Relief of Periodontal Endodontic Syndrome and its Influence on Inflammatory Factors.
WN Ding, M Cheng, ST Fang - Indian Journal of …, 2022 - search.ebscohost.com
To investigate the effect of loxofen sodium tablets on the pain relief of periodontal and pulp
syndrome and its influence on the level of inflammatory factors and to investigate the …
syndrome and its influence on the level of inflammatory factors and to investigate the …
Renoprotective Mechanisms of SGLT2 Inhibitors in Type 2 Diabetes Patients with Chronic Kidney Disease
LHC da Cruz Pinto - PQDT-Global, 2022 - search.proquest.com
Background: Diabetes mellitus is a global epidemic estimated to affect more than 420 million
people worldwide and predicted to impact about 630 million until 2045. Chronic kidney …
people worldwide and predicted to impact about 630 million until 2045. Chronic kidney …
[PDF][PDF] 钠-葡萄糖耦联转运体-2 抑制剂对 2 型糖尿病患者血尿酸影响的研究进展
**小娥， 庞娟娟， 张尊磊， **玉亭 - **医药导报, 2022 - yiyaodaobao.com.cn
血尿酸(UA) 代谢在**常人体内处于动态**衡, 其浓度异常不利于身体健康. 钠, 葡萄糖p
联转运体, 2 抑制剂(SGLT, 2i) 是**年来上市的新型降糖药物, 其能改善2 型糖尿病患者多方面的 …
联转运体, 2 抑制剂(SGLT, 2i) 是**年来上市的新型降糖药物, 其能改善2 型糖尿病患者多方面的 …